Nucleoside Antimetabolite/Analog
Nucleoside antimetabolites and analogs are compounds that mimic natural nucleosides and are incorporated into DNA during replication, leading to chain termination or the inhibition of DNA synthesis. These compounds are widely used as chemotherapeutic agents in the treatment of cancer and viral infections. By disrupting DNA synthesis, nucleoside analogs induce cell cycle arrest and apoptosis. At CymitQuimica, we provide a wide range of high-quality nucleoside antimetabolites and analogs to support your research in cancer treatment, antiviral therapy, and DNA replication.
Found 1420 products of "Nucleoside Antimetabolite/Analog"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
2'-β-C-Methyl-3-deazauri dine
CAS:2’-β-C-Methyl-3-deazauridine, a purine nucleoside analogue, exhibits wide antitumor activity specifically against indolent lymphoid malignancies.Formula:C11H15NO6Color and Shape:SolidMolecular weight:257.245'-O-Benzoyl-3'-O-(4-methoxybenzyl)-2'-O,4'-C-methyleneuridine
5’-O-Benzoyl-3’-O-(4-methoxybenzyl)-2’-O,4’-C-methyleneuridine is a purine nucleoside analog with broad antitumor activity, primarily targeting indolentFormula:C25H24N2O8Color and Shape:SolidMolecular weight:480.472-Diethoxymethyl adenosine
2-Diethoxymethyl adenosine, an adenosine analog, dilates smooth muscle, inhibits cancer, and leads to drugs like Acadesine.Formula:C23H31N5O10Color and Shape:SolidMolecular weight:537.526-Amino-3-(furan-2-yl)-4-methoxy-1-(β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine
6-Amino-3-(furan-2-yl)-4-methoxy-1-(β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine, a purine nucleoside analogue, exhibits broad antitumor activity byFormula:C15H17N5O6Color and Shape:SolidMolecular weight:363.33m7GpppUmpG
CAS:m7GpppUmpG, a trinucleotide cap analogue, enables RNA synthesis with cap 0 or 1 structures.Formula:C31H42N12O26P4Color and Shape:SolidMolecular weight:1122.63m7GpppGpG
CAS:m7GpppGpG, a trinucleotide cap, protects mRNA from 5′ exonucleases & aids splicing and translation.Formula:C31H41N15O25P4Color and Shape:SolidMolecular weight:1147.645'-O-DMTr-2'-O-MOE inosine 3'-P-methyl phosphonamidite
5’-O-DMTr-2’-O-MOE inosine 3’-P-methyl phosphonamidite, a purine nucleoside analog, exhibits extensive antitumor activity specific to indolent lymphoidFormula:C41H52N5O8PColor and Shape:SolidMolecular weight:773.85N4-Benzoyl-2'-deoxy-2'-fluoro-β-D-arabinocytidine
N4-Benzoyl-2’-deoxy-2’-fluoro-β-D-arabinocytidine, a purine nucleoside analog, exhibits widespread antitumor activity, particularly against indolent lymphoidFormula:C16H16FN3O5Color and Shape:SolidMolecular weight:349.318-Chloro-2'-deoxy-2'-fluoro-arabino adenosine
8-Chloro-2’-deoxy-2’-fluoro-arabino adenosine, a purine nucleoside analog, demonstrates broad antitumor activity against indolent lymphoid malignancies.Formula:C10H11ClFN5O3Color and Shape:SolidMolecular weight:303.68N1-Methyl-2'-O-(2-methoxyethyl) guanosine
N1-Methyl-2’-O-(2-methoxyethyl) guanosine, a purine nucleoside analog, exhibits broad antitumor activity against indolent lymphoid malignancies.Formula:C14H21N5O6Color and Shape:SolidMolecular weight:355.35Fostroxacitabine bralpamide
CAS:Fostroxacitabine bralpamide (MIV-818) is an orally active Troxacitabine-based nucleotide prodrug. Fostroxacitabine bralpamide has anticancer effects.Formula:C22H30BrN4O8PColor and Shape:SolidMolecular weight:589.37(R)-N-(2,3-Dihydro-1H-indenyl)-2-amino adenosine
(R)-N-(2,3-Dihydro-1H-indenyl)-2-amino adenosine, a purine analog, targets lymphoid cancer via DNA synthesis inhibition and apoptosis.Formula:C19H22N6O4Color and Shape:SolidMolecular weight:398.422-(P-Cyanophenyl methylidene hydrazino) adenosine
2-(P-Cyanophenyl methylidene hydrazino) adenosine: a purine analog with antitumor effects via DNA synthesis inhibition and apoptosis.Formula:C18H18N8O4Color and Shape:SolidMolecular weight:410.392'-O-Methyl-5-methyluridine 5'-triphosphate triethylammonium
2’-O-Methyl-5-methyluridine 5’-triphosphate (triethylammonium), a thymidine analog, exhibits insertional activity in replicated DNA.Formula:C29H64N5O15P3Color and Shape:SolidMolecular weight:815.763'-O-(4,4'-Dimethoxy trityl)-2'-O-(2-methoxyethyl)-5-methyluridine
3’-O-(4,4’-Dimethoxy trityl)-2’-O-(2-methoxyethyl)-5-methyluridine, a purine nucleoside analog, exhibits extensive antitumor properties against indolentFormula:C34H38N2O9Color and Shape:SolidMolecular weight:618.673'-O-DMT-N2-isobutyryl-2'-O-(2-methoxyethyl)guanosine
3’-O-DMT-N2-isobutyryl-2’-O-(2-methoxyethyl)guanosine, a purine nucleoside analog, exhibits broad antitumor activity particularly against indolent lymphoidFormula:C38H43N5O9Color and Shape:SolidMolecular weight:713.785-(2-Hydroxyethyl)-2',3'-di-O-toluoyl-2'-deoxyuridine
5-(2-Hydroxyethyl)-2',3'-di-O-toluoyl-2'-deoxyuridine, a purine nucleoside analog, exhibits widespread antitumor activity specifically against indolent lymphoidFormula:C27H28N2O8Color and Shape:SolidMolecular weight:508.522'-Deoxy-2'-fluoroadenosine 5'-monophosphate triethylammonium
2’-Deoxy-2’-fluoroadenosine 5’-monophosphate (triethylammonium) is a purine nucleoside analog with extensive antitumor properties, particularly effectiveFormula:C22H43FN7O6PColor and Shape:SolidMolecular weight:551.59Rev 2'-O-MOE-A(Bz)-5'-amidite
'Rev 2’-O-MOE-A(Bz)-5’-amidite is a nucleoside analog specifically categorized within the purine subset, renowned for its wide-ranging antitumor efficacyFormula:C50H58N7O9PColor and Shape:SolidMolecular weight:932.01Flurocitabine HCl
CAS:Fluorocitabine HCl, a cytarabine analog, hydrolyzes into ara-FC and ara-FU, showing antitumor effects in leukemia and solid cancers.Formula:C9H11ClFN3O4Purity:99.23% - 99.76%Color and Shape:SoildMolecular weight:279.65
